200 related articles for article (PubMed ID: 6106099)
21. Pneumococcal polysaccharide immunization in infants and children.
Cowan MJ; Ammann AJ; Wara DW; Howie VM; Schultz L; Doyle N; Kaplan M
Pediatrics; 1978 Nov; 62(5):721-7. PubMed ID: 31592
[TBL] [Abstract][Full Text] [Related]
22. Impaired immunity to pneumococcal polysaccharide antigens in children with human immunodeficiency virus infection immunized with pneumococcal vaccine.
Peters VB; Diamant EP; Hodes DS; Cimino CO
Pediatr Infect Dis J; 1994 Oct; 13(10):933-4. PubMed ID: 7854897
[No Abstract] [Full Text] [Related]
23. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.
Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC
N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575
[TBL] [Abstract][Full Text] [Related]
24. Use of pneumococcal polysaccharide vaccine in children.
Mulholland K; Usen S; Adegbola R; Weber M
Lancet; 1998 Aug; 352(9127):575-6. PubMed ID: 9716087
[No Abstract] [Full Text] [Related]
25. Impaired response to pneumococcal vaccine in Hodgkin's disease.
Cadman E; Cohen MS; Root RK; Ryan JL; Minor DR
N Engl J Med; 1978 Dec; 299(23):1317-8. PubMed ID: 30897
[No Abstract] [Full Text] [Related]
26. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
Robbins JB; Austrian R; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J; Mäkelä PH; Broome CV; Facklam RR; Tiesjema RH
J Infect Dis; 1983 Dec; 148(6):1136-59. PubMed ID: 6361173
[No Abstract] [Full Text] [Related]
27. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.
Giebink GS; Foker JE; Kim Y; Schiffman G
J Infect Dis; 1980 Mar; 141(3):404-12. PubMed ID: 6988526
[No Abstract] [Full Text] [Related]
28. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats.
Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA
J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606
[TBL] [Abstract][Full Text] [Related]
29. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics.
Beam TR; Crigler ED; Goldman JK; Schiffman G
JAMA; 1980 Dec; 244(23):2621-4. PubMed ID: 7431608
[TBL] [Abstract][Full Text] [Related]
30. Fold-increase in antibody titer upon vaccination with pneumococcal unconjugated polysaccharide vaccine.
Borgers H; Meyts I; De Boeck K; Raes M; Sauer K; Proesmans M; Moens L; Jeurissen A; Flamaing J; Peetermans WE; Verhaegen J; Bossuyt X
Clin Immunol; 2012 Nov; 145(2):136-8. PubMed ID: 23026475
[No Abstract] [Full Text] [Related]
31. Response of traumatized splenectomized patients to immediate vaccination with polyvalent pneumococcal vaccine.
Caplan ES; Boltansky H; Snyder MJ; Rooney J; Hoyt NJ; Schiffman G; Cowley RA
J Trauma; 1983 Sep; 23(9):801-5. PubMed ID: 6620433
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive drugs impairs antibody response of the polysaccharide and conjugated pneumococcal vaccines in patients with Crohn's disease.
Kantsø B; Halkjær SI; Thomsen OØ; Belard E; Gottschalck IB; Jørgensen CS; Krogfelt KA; Slotved HC; Ingels H; Petersen AM
Vaccine; 2015 Oct; 33(41):5464-5469. PubMed ID: 26275480
[TBL] [Abstract][Full Text] [Related]
33. Vaccine-type pneumococcal pneumonia. Occurrence after vaccination in an asplenic patient.
Giebink GS; Schiffman G; Krivit W; Quie PG
JAMA; 1979 Jun; 241(25):2736-7. PubMed ID: 36484
[No Abstract] [Full Text] [Related]
34. Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines.
Austrian R
J Infect Dis; 1977 Aug; 136 Suppl():S38-42. PubMed ID: 19543
[TBL] [Abstract][Full Text] [Related]
35. Immune response after splenectomy.
Sullivan JL; Ochs HD; Schiffman G; Hammerschlag MR; Miser J; Vichinsky E; Wedgwood RJ
Lancet; 1978 Jan; 1(8057):178-81. PubMed ID: 74605
[TBL] [Abstract][Full Text] [Related]
36. Impact of Using Different Response Criteria for Pneumococcal Polysaccharide Vaccination for Assessment of Humoral Immune Status.
Hoffman TW; van Kessel DA; Rijkers GT
J Clin Immunol; 2018 Feb; 38(2):149-152. PubMed ID: 29247371
[No Abstract] [Full Text] [Related]
37. Antibody responses to pneumococcal capsular polysaccharide: what is being measured?
Goldblatt D; Jadresic LP; Levinsky RJ; Turner MW
Immunodeficiency; 1993; 4(1-4):47-50. PubMed ID: 8167732
[No Abstract] [Full Text] [Related]
38. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
[TBL] [Abstract][Full Text] [Related]
39. Pneumococcal vaccine failure in a splenectomized child.
Koren A; Efrati Z; Algazi J; Katzuni E
Infect Control; 1984 Dec; 5(12):556. PubMed ID: 6569852
[No Abstract] [Full Text] [Related]
40. [Failure of anti-pneumococcal vaccination and prophylactic antibiotic therapy in 2 splenectomized subjects].
Herer B; Brivet F; Fremaux A; Geslin P; Guibert M; Tchernia G; Dormont J
Nouv Rev Fr Hematol (1978); 1986; 28(6):371-6. PubMed ID: 3562220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
